Cellworks Group's Series B Round

Cellworks Group raised a round of funding on March 06, 2012. Investors include Artiman Ventures.

Cellworks Group is a biopharmaceutical therapeutic design and development company based on platform predicting clinical outcomes. The company has designed therapies that are substantially derisked wit…

Articles about Cellworks Group's Series B Round: